Kegg medicus dgroup
| DG01508 | |
| DG番号 | DG01508 |
| 分類 | DGroup |
| 名称 | Sulfonylurea receptor agonist TYPE Target |
| ステム | - |
| 構造式 |  |
| メンバー | DG01734 Sulfonylurea D00336 Glyburide (USP); Glibenclamide (JP18/INN) D00271 Chlorpropamide (JP18/USP/INN) DG00115 Tolbutamide D00380 Tolbutamide (JP18/USP/INN) D06177 Tolbutamide sodium, sterile D02427 Glibornuride (USAN/INN) D00379 Tolazamide (JAN/USP/INN) D02425 Carbutamide (INN) D00335 Glipizide (USP/INN) D02430 Gliquidone (INN) D01599 Gliclazide (JP18/INN) D07117 Metahexamide (INN) D07118 Glisoxepide (INN) D00593 Glimepiride (JP18/USP/INN) D00219 Acetohexamide (JP18/USP/INN) D01799 Glyclopyramide (JAN/INN) D02426 Glycyclamide (INN) D02428 Glisentide (INN) D02429 Glisolamide (INN) D04322 Gliamilide (USAN/INN) D04354 Glyhexamide (USAN/INN) D04355 Glyoctamide (USAN/INN) D04356 Glyparamide (USAN) D06186 Tolpyrramide (USAN/INN) D01356 Glymidine sodium (JAN/USAN/INN) DG01735 Glinide D00594 Repaglinide (JAN/USP/INN) D01111 Nateglinide (JP18/USP/INN) D01854 Mitiglinide calcium hydrate (JP18) |
| 上位グループ | Antidiabetic agent |
| 注釈1 | - |
| 注釈2 | - |